- Home
- MTSI vs RGC Comparison
MTSI vs RGC Comparison
Compare MTSI & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTSI
- RGC
- Stock Information
- Founded
- MTSI 1950
- RGC 2014
- Country
- MTSI United States
- RGC Hong Kong
- Employees
- MTSI N/A
- RGC N/A
- Industry
- MTSI Semiconductors
- RGC Medicinal Chemicals and Botanical Products
- Sector
- MTSI Technology
- RGC Health Care
- Exchange
- MTSI Nasdaq
- RGC Nasdaq
- Market Cap
- MTSI 9.2B
- RGC 8.4B
- IPO Year
- MTSI 2012
- RGC 2021
- Fundamental
- Price
- MTSI $148.13
- RGC $16.65
- Analyst Decision
- MTSI Strong Buy
- RGC
- Analyst Count
- MTSI 7
- RGC 0
- Target Price
- MTSI $147.71
- RGC N/A
- AVG Volume (30 Days)
- MTSI 936.7K
- RGC 194.3K
- Earning Date
- MTSI 11-06-2025
- RGC 10-24-2025
- Dividend Yield
- MTSI N/A
- RGC N/A
- EPS Growth
- MTSI N/A
- RGC N/A
- EPS
- MTSI N/A
- RGC N/A
- Revenue
- MTSI $906,798,000.00
- RGC N/A
- Revenue This Year
- MTSI $35.10
- RGC N/A
- Revenue Next Year
- MTSI $13.73
- RGC N/A
- P/E Ratio
- MTSI N/A
- RGC N/A
- Revenue Growth
- MTSI 33.50
- RGC N/A
- 52 Week Low
- MTSI $84.00
- RGC $0.09
- 52 Week High
- MTSI $154.86
- RGC $83.60
- Technical
- Relative Strength Index (RSI)
- MTSI 62.84
- RGC 48.15
- Support Level
- MTSI $133.39
- RGC $15.79
- Resistance Level
- MTSI $154.81
- RGC $17.45
- Average True Range (ATR)
- MTSI 4.70
- RGC 1.11
- MACD
- MTSI 1.36
- RGC -0.01
- Stochastic Oscillator
- MTSI 76.04
- RGC 37.65
About MTSI MACOM Technology Solutions Holdings Inc.
MACOM Technology Solutions Holdings Inc is a provider of analog, digital, and mixed-signal semiconductor solutions to original equipment manufacturers and distributors. These solutions are found in systems for industrial, medical, scientific, and test and measurement markets. The firm's portfolio of products includes integrated circuits, multichip modules, power pallets and transistors, diodes, amplifiers, switches and switch limiters, passive and active components, and complete subsystems. Roughly a third of the firm's revenue is generated in the United States, with the rest coming from China, Japan, Singapore, South Korea, and other countries across the world.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.